EA Pharma is a French pharmaceutical company founded in 2016 with a focus on improving people's quality of life through natural means. The company specializes in micro-nutrition, Nutritherapy Complementary Therapy, and Oligotherapy. Their core values revolve around innovation, excellence, quality, transparency, and consumer/patient service. With a strong expertise in both medical and nutritional fields, they cater to the needs of Health, Sports, and Well-being sectors. The company recently received Debt Financing investment on 01 September 2022 from Muzinich & Co. EA Pharma's dedication to natural health, innovation, effectiveness, and performance, as expressed in their slogan, makes them an intriguing prospect for investors in the pharmaceutical industry.
No recent news or press coverage available for EA Pharma.